Erasca, Inc.

ERAS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
SCHEDULE 13G/A May 15, 2026
SCHEDULE 13G/A May 15, 2026
SCHEDULE 13G/A May 15, 2026
SCHEDULE 13G May 15, 2026
SCHEDULE 13G/A May 12, 2026
10-Q May 11, 2026 10-Q
8-K May 11, 2026 8-K
ARS Apr 28, 2026 ARS
DEFA14A Apr 28, 2026 DEFA14A
DEF 14A Apr 28, 2026 DEF 14A
8-K Apr 27, 2026 8-K
8-K Apr 27, 2026 8-K
8-K Apr 21, 2026 8-K
144/A Apr 15, 2026
144 Apr 15, 2026
4 Apr 3, 2026 4
144 Apr 1, 2026
144 Mar 16, 2026
10-K Mar 12, 2026 10-K
8-K Mar 12, 2026 8-K
4 Mar 6, 2026 4
144 Mar 4, 2026
144 Feb 17, 2026
SCHEDULE 13G/A Feb 17, 2026
4 Jan 30, 2026 4
← Newer Page 2 of 14 · 350 filings Older →